Pfizer's 7.5% dividend yield, strong R&D innovation, and defensive market position make it a smart buy. Read here for an ...

Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

In partnership with NMA, Charles Drew University of Medicine and Science and the National Minority Quality Forum, BDO and The ...

UC San Diego's Moores Cancer Center has received a $1 million donation from pharmaceutical giant Pfizer to support early ...

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best healthcare ...

Now given Pfizer's growing pipeline of new drug launches ... other mechanisms of action to address this growing global health challenge. Pfizer has a huge pipeline of new drugs that can hit ...

Pfizer's modest price change may reflect resilience given such context. The modest gain aligns with the company's efforts in advancing its healthcare initiatives, such as the FDA Fast Track ...

Pfizer has unveiled its new research and development centre in Beijing, marking a significant step in the company's strategic expansion in China.